John Armitage Boston Scientific Corp Transaction History
Egerton Capital (Uk) LLP
- $7.88 Billion
- Q3 2025
A detailed history of John Armitage (Egerton Capital (Uk) LLP) transactions in Boston Scientific Corp stock. As of the latest transaction made, Egerton Capital (Uk) LLP holds 5,312,504 shares of BSX stock, worth $546 Million. This represents 6.58% of its overall portfolio holdings.
Number of Shares
5,312,504
Previous 1,640,956
223.74%
Holding current value
$546 Million
Previous $176 Million
194.27%
% of portfolio
6.58%
Previous 2.19%
Shares
2 transactions
Others Institutions Holding BSX
# of Institutions
1,950Shares Held
1.26BCall Options Held
10.9MPut Options Held
8.94M-
Vanguard Group Inc Valley Forge, PA138MShares$14.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.9MShares$6.67 Billion0.23% of portfolio
-
Bank Of America Corp Charlotte, NC33.9MShares$3.48 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA33.1MShares$3.4 Billion2.56% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...